These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22093169)

  • 1. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
    Chinen CC; Frussa-Filho R
    Neuropsychopharmacology; 1999 Nov; 21(5):670-8. PubMed ID: 10516963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
    Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
    Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A; Kulkarni SK
    Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats.
    Galaj E; Manuszak M; Arastehmanesh D; Ranaldi R
    Behav Brain Res; 2014 Oct; 272():279-85. PubMed ID: 25017572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact?
    Colombo AC; de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2013 Nov; 257():201-7. PubMed ID: 24120401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1 but not D2 dopamine receptor antagonism blocks the acquisition of a flavor preference conditioned by intragastric carbohydrate infusions.
    Azzara AV; Bodnar RJ; Delamater AR; Sclafani A
    Pharmacol Biochem Behav; 2001 Apr; 68(4):709-20. PubMed ID: 11526968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NMDA, opioid and dopamine D1 and D2 receptor signaling in the acquisition of a quinine-conditioned flavor avoidance in rats.
    Rotella FM; Badalia A; Duenas SM; Hossain M; Saeed S; Touzani K; Sclafani A; Bodnar RJ
    Physiol Behav; 2014 Apr; 128():133-40. PubMed ID: 24508751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral sensitization to apomorphine in pigeons (Columba livia): blockade by the D1 dopamine antagonist SCH-23390.
    Acerbo MJ; Delius JD
    Behav Neurosci; 2004 Oct; 118(5):1080-8. PubMed ID: 15506890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
    Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning.
    Martin-Iverson MT; McManus DJ
    Brain Res; 1990 Jun; 521(1-2):175-84. PubMed ID: 2145055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.